Trials / Completed
CompletedNCT04620616
Nicotine Uptake, Measures of Abuse Liability, and Puffing Topography With Use of RELX ENDS Products by ENDS Consumers
A Randomized, Open-Label, Multi-Center, Cross-Over Study of Adult Electronic Nicotine Delivery Systems (ENDS) Consumers to Assess Nicotine Uptake, Measures of Abuse Liability, and Puffing Topography With RELX Infinity ENDS
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 29 (actual)
- Sponsor
- Cheerain HK Limited · Industry
- Sex
- All
- Age
- 22 Years – 59 Years
- Healthy volunteers
- Accepted
Summary
This study is being conducted to evaluate nicotine uptake, the potential abuse liability, and puffing topography associated with the use of an electronic nicotine delivery system (ENDS) with tobacco- and menthol-flavored e-liquids in current ENDS consumers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | RELX ENDS Tobacco Flavor | Ad libitum use of the RELX ENDS tobacco flavor product during 8-hour and 5-minute use sessions |
| OTHER | RELX ENDS Menthol Flavor | Ad libitum use of the RELX ENDS tobacco flavor product during 8-hour and 5-minute use sessions |
| OTHER | Subject Usual Brand ENDS | Ad libitum use of the usual brand product during 8-hour and 5-minute use sessions |
Timeline
- Start date
- 2020-09-11
- Primary completion
- 2021-01-04
- Completion
- 2021-01-14
- First posted
- 2020-11-09
- Last updated
- 2021-01-19
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT04620616. Inclusion in this directory is not an endorsement.